Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10007641HBVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS10025136HBVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS10029588HBVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS10040820HBVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS30016228HIVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS30075120HIVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS30059944HIVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS30059945HIVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS30059946HIVENSG00000135605.13protein_codingTECNoNo7006P42680
TVIS30059947HIVENSG00000135605.13protein_codingTECNoNo7006P42680
TCGA Plot Options
Drug Information
GeneTEC
DrugBank IDDB14924
Drug NameRitlecitinib
Target IDBE0009385
UniProt IDP42680
Regulation Typeinhibitor
PubMed IDs35210753
CitationsRamirez-Marin HA, Tosti A: Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata. Drug Des Devel Ther. 2022 Feb 17;16:363-374. doi: 10.2147/DDDT.S334727. eCollection 2022.
GroupsApproved; Investigational
Direct Classification
SMILESC[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2
Pathways
PharmGKB
ChEMBLCHEMBL4085457